Loading...
Portfolio Diversification
Range
Most Diversified
18 instruments
August 28, 2026
Least Diversified
0 instruments
August 27, 2023
Average
12.2 instruments
Most Consistent Holdings
Top 5
REGN94.55%
FLGT91.82%
SMTC87.55%
AUPH86.91%
AZN84.36%
Position Sizing
Analysis
Market Exposure
Analysis
Top Sectors
Top 5
Top Countries
Top 5
Holdings over time
(Since August 27, 2023)
| Instrument | Avg. Exposure | Current Exposure | Time Holding | Last Closed |
|---|---|---|---|---|
| Semtech (SMTC) | 11.87% | 8.98% | 87.55% | - |
| Fulgent (FLGT) | 8.4% | 5.02% | 91.82% | - |
 Inari Medical (NARI) | 7.61% | 0% | 44.27% | 1/15/2025 |
| Aurinia (AUPH) | 7.25% | 2.46% | 86.91% | - |
 STAAR Surgical (STAA) | 6.29% | 0% | 62.64% | 8/5/2025 |
| Regeneron (REGN) | 5.14% | 5.79% | 94.55% | - |
 Roche (ROP.ZU) | 4.57% | 4.77% | 52.09% | - |
 Axonics (AXNX) | 4.41% | 0% | 9.55% | 12/14/2023 |
 CRISPR Therapeutics (CRSP) | 4.05% | 7.71% | 61.64% | - |
| AstraZeneca (AZN) | 3.49% | 6.05% | 84.36% | - |
 GE HealthCare (GEHC) | 3.41% | 0% | 35.45% | 2/13/2025 |
 Lyell Immunopharma (LYEL) | 3.12% | 10.19% | 59.36% | - |
 Amphastar (AMPH) | 2.18% | 9.55% | 34.91% | - |
 Argenx (ARGX) | 2.1% | 0% | 30.36% | 12/10/2024 |
 Castle Biosciences (CSTL) | 2.05% | 10.4% | 34.91% | - |
 89Bio (ETNB) | 2.01% | 0% | 30.64% | 11/4/2025 |
 Mueller Industries (MLI) | 1.83% | 5.8% | 34.91% | - |
 Moderna (MRNA) | 1.78% | 10.46% | 33% | - |
 Illumina (ILMN) | 1.72% | 0% | 51.82% | 8/25/2026 |
 Intel (INTC) | 1.38% | 0% | 26.09% | 9/15/2025 |
 Sage (SAGE) | 1.08% | 0% | 24.18% | 8/5/2025 |
 Lantheus (LNTH) | 0.76% | 3.24% | 21.64% | - |
 Catalyst Pharmaceuticals (CPRX) | 0.68% | 0% | 17.18% | 7/17/2026 |
 AMD (AMD) | 0.65% | 0% | 19.73% | 8/22/2025 |
 Caterpillar (CAT) | 0.42% | 0% | 18.18% | 12/2/2024 |
 RudolfDeLeeuw | 0.36% | 0% | 3.91% | 8/2/2024 |
 Intra-Cellular (ITCI) | 0.13% | 0% | 3.18% | 5/3/2024 |
 NEXTracker (NXT.US) | 0.04% | 0% | 1.27% | 8/22/2025 |
 Tscan Therapeutics (TCRX) | 0.02% | 3.29% | 0.82% | - |
 Tenaya Therapeutics (TNYA) | 0.01% | 1.51% | 0.82% | - |
 Reneo Pharmaceuticals (OKUR) | 0.01% | 1.39% | 0.82% | - |
 ETNB CVR Merger (ETNB CVR) | 0% | 0% | 0% | - |
 Sage CVR delisting (SAGE CVR) | 0% | 0% | 0% | - |
Exposure over time
Exposure by Sector
Exposure by Country
Portfolio Time Machine
Portfolio date
01
01
2026
| Instrument | Invested | Value |
|---|---|---|
| Lyell Immunopharma (LYEL) | 7.4% | 7.89% |
| Semtech (SMTC) | 7.58% | 7.69% |
| Roche (ROP.ZU) | 7.24% | 7.64% |
| Regeneron (REGN) | 7.23% | 6.49% |
| Aurinia (AUPH) | 5.96% | 6.44% |
| Fulgent (FLGT) | 6.55% | 6.02% |
| Amphastar (AMPH) | 5.96% | 5.88% |
| CRISPR Therapeutics (CRSP) | 7.15% | 5.74% |
| Illumina (ILMN) | 4.75% | 5.48% |
| AstraZeneca (AZN) | 4.77% | 5.01% |
| Castle Biosciences (CSTL) | 3.57% | 4.99% |
| Moderna (MRNA) | 4.77% | 4.48% |
| Mueller Industries (MLI) | 3.57% | 3.98% |
| Catalyst Pharmaceuticals (CPRX) | 1.19% | 1.08% |
| Lantheus (LNTH) | 1.19% | 1.07% |
| ETNB CVR Merger (ETNB CVR) | 0% | 0% |
| Sage CVR delisting (SAGE CVR) | 0% | 0% |
Cash & Instruments Over Time
Unlock Premium Features
Get access to this feature and many more with BullAware Pro.